News & Articles

Discover how BRANDTECH’s latest pipette allows temporary fine-tuning for different liquids, temperatures, and tip styles

The U.S. FDA has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH)

Equipped with the READY System to make structural biology research accessible to more labs

Prospective UT MD Anderson study shows RNA analysis expands on treatment options beyond DNA testing

See how Honeywell and METTLER TOLEDO collaborated to unlock new frontiers for Hydranal reagent formulation via automated titration

Advancing efficiency and uptime in gas chromatography

Dr. Becky Upton, President of Pistoia Alliance, looks to the future of lab innovation in this guest editorial

How Roche and Disease Management Consulting empower laboratory professionals to drive strategic value in healthcare systems

Showcased at AACR 2026 with data from leading research institutions, including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ)

From spreadsheet silos to AI-powered insights, discover how Signals software is streamlining formulation science

IDE approval by the FDA expands global trial to the United States as first study participant is treated in the United Kingdom

Co-occurrence of myocarditis with myositis and myasthenia gravis may also increase risk of death

Discover how SelectScience clinical CE webinars are supporting biomedical scientists and laboratory professionals in achieving diagnostic excellence during Medical Lab Professionals Week 2026

Biodesix, Inc. to present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting

Data presented at the AACR 2026 revealed a 44% reduction and growing urban concentration of U.S. phase I NSCLC trial sites between 2020 and 2024

Discover how Amnion Laboratory Director Paul Behrends is bridging the gap between facility infrastructure and clinical innovation to celebrate Medical Laboratory Professionals Week 2026

Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies.

This approach may eventually help guide personalized treatment decisions for patients diagnosed with these cancers

In this guest editorial, Richard Knight Senior Director, Medical Affairs, Thermo Fisher Scientific, explores how success in transplantation is measured in years, not hours, and how lab professionals provide the critical data needed to navigate the high-stakes journey of post-operative care

All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of follow-up

National Institutes of Health awards The Research OutSmarts Endometriosis team an $850,000 prize over one year to accelerate the development of a non-invasive diagnostic test

The Content Innovation Engine integrates Akoya's spatial biology platform and Quanterix's immunoassay infrastructure to unlock cancer biology and accelerate clinical application

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic NSCLC